genprowebdirectory
GEN Edge
Video & Multimedia
Latest News
Login
Subscribe
News
Insights
Trends for 2020
Trends for 2021
Topics
Bioprocessing
Cancer
Drug Discovery
Genome Editing
OMICs
Translational Medicine
A-Lists
Magazine
Current Issue
Past Issues
Supplements
Subscribe
Resources
GEN Protocols
Summits
Webinars
GEN Live
eBooks
Podcasts
Tutorials
Peer-Reviewed Journals
Re:Gen Open
New Products
Best of the Web
Best Apps
Conference Calendar
Subscribe
Create a Free Account
Get GEN Edge
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Search
Advertising
Magazine Advertising
Website Banner Advertising
eNewsletter Advertising
Webinar Sponsorship
eBook Advertising
Email Nurture Campaigns
Ad Terms and Conditions
About GEN
Contact GEN
Create a Free Account
Get GEN Edge
Log In
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Create an account
Privacy Policy
Create an account
Welcome! Register for an account
your email
your username
A password will be e-mailed to you.
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
GEN – Genetic Engineering and Biotechnology News
GEN Edge
Video & Multimedia
Latest News
Login
Subscribe
News
Gene Therapy
Astellas, Dyno Launch Up-to-$1.6B+ Gene Therapy Collaboration
Autism
Autism-Linked ANK2 Gene Variants Alter Neuronal Architecture, Organization
3D Printing
Wound Healing Gets a Boost from 3D Printed Platelet-Rich Plasma
Alzheimers
Circadian Clock Neuron Study May Also Shed Light on Major Neurodisorders
Infectious Diseases
Zika and Dengue Neutralizing Human Antibody Distorts Dengue but Not Zika
Insights
All
Trends for 2020
Trends for 2021
Antibiotics
Bioprocessing in the Pasture
Gene Therapy
Cell and Gene Therapy Sector Needs CMC Clarity
Gene Therapy
3D Bioreactor Shows Promise for Donor Cell Therapies
Bioprocessing
Valneva Inks Covid Vaccine Production Deal with IDT Biologika
Topics
Bioprocessing
Cancer
Drug Discovery
Genome Editing
OMICs
Translational Medicine
A-Lists
A-Lists
Top 10 RNA-Based Biopharmas
Coronavirus
Top 11 Best Selling COVID-19 Vaccines and Drugs of H1 2021
A-Lists
Top 10 Spatial Biology Companies
A-Lists
Top 10 Synthetic Biology Companies
A-Lists
Seven Up-and-Coming COVID-19 Drugs
Magazine
Current Issue
Past Issues
Supplements
Subscribe
Resources
GEN Protocols
Summits
Webinars
GEN Live
eBooks
Podcasts
Tutorials
Peer-Reviewed Journals
Re:Gen Open
New Products
Best of the Web
Best Apps
Conference Calendar
Subscribe
Create a Free Account
Get GEN Edge
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Home
Genome Editing
Gene Therapy
Gene Therapy
CRISPR-Cas9
Gene Therapy
Synthetic Biology
Most popular
Latest
Featured posts
Most popular
7 days popular
By review score
Random
GEN Live
Gene Therapy: What’s Up With AAV?
GEN Live
COVID-19: The Push for a Vaccine
On Demand Webinars
Improving Plasmid and Viral Vectors in Cell and Gene Therapy
Gene Therapy
Novel Nano System Delivers mRNA to Inflammatory Leukocytes
Gene Therapy
Ophthotech Expands Eye Disease Pipelines of Small Molecule, Gene Therapy Candidates
Gene Therapy
GenVec and Novartis Cement Hearing Loss Partnership with Manufacturing Deal
Gene Therapy
Oxford BioMedica, Bioverativ to Develop Lentiviral Vectors for Hemophilia Gene Therapy
Gene Therapy
Unlocking the Potential of CRISPR-Based Gene Editing
Gene Therapy
Lonza Opens Cell and Gene Therapy Facility in Pearland, TX
Gene Therapy
Improving Brain Function Boosts Memory Retrieval
Gene Therapy
Renova Licenses Janssen’s IND File for Stresscopin
Gene Therapy
Increasing Eye Cells’ Ability to Process Misfolded Proteins May Prevent Retinal...
Gene Therapy
Installing “Smartly Formulated” Receptors Improves Function of Diseased Hearts
Gene Therapy
Regeneron to Invest $100M in bluebird bio as Companies Partner in...
Gene Therapy
Fujifilm Expands Fill Finish Services
1
2
3
...
41
Page 1 of 41
Scroll Up
![Source: Retinitis pigmentosa by Christian Hamel [CC BY-SA 3.0]](https://www.genengnews.com/wp-content/uploads/2018/08/May2_2018_Wikipedia_RetinitisPigmentosa2151735414-324x160.jpg "Increasing Eye Cells’ Ability to Process Misfolded Proteins May Prevent Retinal Degeneration")
![Regeneron Pharmaceuticals demonstrated its VelocImmune technology in a study published in 2015 in Proceedings of the National Academy of Sciences showing the rapid generation of fully human neutralizing antibodies against Middle East Respiratory Syndrome coronavirus (MERS-CoV) and development of a humanized mouse model for MERS-CoV infection (pictured). Regeneron will use VelocImmune and other VelociSuite platform technologies in a collaboration with bluebird bio to develop new immune cell therapies for cancer. [Source: PNAS]](https://www.genengnews.com/wp-content/uploads/2018/08/F7large2321726613-324x160.jpg "Regeneron to Invest $100M in bluebird bio as Companies Partner in Cancer Therapies")